Literature DB >> 22057666

An analysis of the influence of framework aspects on the study design of health economic modeling evaluations.

Sebastian Gurtner1.   

Abstract

Research and practical guidelines have many implications for how to structure a health economic study. A major focus in recent decades has been the quality of health economic research. In practice, the factors influencing a study design are not limited to the quest for quality. Moreover, the framework of the study is important. This research addresses three major questions related to these framework aspects. First, we want to know whether the design of health economic studies has changed over time. Second, we want to know how the subject of a study, whether it is a process or product innovation, influences the parameters of the study design. Third, one of the most important questions we will answer is whether and how the study's source of funding has an impact on the design of the research. To answer these questions, a total of 234 health economic studies were analyzed using a correspondence analysis and a logistic regression analysis. All three categories of framework factors have an influence on the aspects of the study design. Health economic studies have evolved over time, leading to the use of more advanced methods like complex sensitivity analyses. Additionally, the patient's point of view has increased in importance. The evaluation of product innovations has focused more on utility concepts. On the other hand, the source of funding may influence only a few aspects of the study design, such as the use of evaluation methods, the source of data, and the use of certain utility measures. The most important trends in health care, such as the emphasis on the patients' point of view, become increasingly established in health economic evaluations with the passage of time. Although methodological challenges remain, modern information and communication technologies provide a basis for increasing the complexity and quality of health economic studies if used frequently.

Entities:  

Mesh:

Year:  2011        PMID: 22057666     DOI: 10.1007/s10198-011-0363-6

Source DB:  PubMed          Journal:  Eur J Health Econ        ISSN: 1618-7598


  18 in total

1.  The quality of reporting in published cost-utility analyses, 1976-1997.

Authors:  P J Neumann; P W Stone; R H Chapman; E A Sandberg; C M Bell
Journal:  Ann Intern Med       Date:  2000-06-20       Impact factor: 25.391

2.  Regulating the economic evaluation of pharmaceuticals and medical devices: a European perspective.

Authors:  Richard Cookson; John Hutton
Journal:  Health Policy       Date:  2003-02       Impact factor: 2.980

Review 3.  [Health economic studies in dermatology--review of the literature, evaluation and practical aspects].

Authors:  Christina Rogalski; Uwe Paasch; Jan Christoph Simon
Journal:  J Dtsch Dermatol Ges       Date:  2004-04       Impact factor: 5.584

4.  Health care reform in Germany: patchwork change within established governance structures.

Authors:  Christa Altenstetter; Reinhard Busse
Journal:  J Health Polit Policy Law       Date:  2005 Feb-Apr       Impact factor: 2.265

5.  Decision-analytical modelling in health-care economic evaluations.

Authors:  Xin Sun; Thomas Faunce
Journal:  Eur J Health Econ       Date:  2007-10-18

6.  A clinician's guide to correct cost-effectiveness analysis: think incremental not average.

Authors:  Jeffrey S Hoch; Carolyn S Dewa
Journal:  Can J Psychiatry       Date:  2008-04       Impact factor: 4.356

7.  Economic analyses of radiological procedures: a methodological evaluation of the medical literature.

Authors:  C C Blackmore; W J Smith
Journal:  Eur J Radiol       Date:  1998-05       Impact factor: 3.528

8.  Cost-of-illness studies: fact or fiction?

Authors:  D P Rice
Journal:  Lancet       Date:  1994-12-03       Impact factor: 79.321

Review 9.  Measuring outcomes in oncology treatment: the importance of patient-centered outcomes.

Authors:  Aundrea Oliver; Caprice C Greenberg
Journal:  Surg Clin North Am       Date:  2009-02       Impact factor: 2.741

10.  Future costs in cost-effectiveness analysis: an empirical assessment.

Authors:  Marie Kruse; Jan Sørensen; Dorte Gyrd-Hansen
Journal:  Eur J Health Econ       Date:  2010-09-28
View more
  1 in total

1.  The cost-utility of school-based first permanent molar sealants programs: a Markov model.

Authors:  Gerardo Espinoza-Espinoza; Gilda Corsini; Rubén Rojas; Rodrigo Mariño; Carlos Zaror
Journal:  BMC Oral Health       Date:  2019-12-30       Impact factor: 2.757

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.